LRF/ZBTB7A gene expression levels in patients who received hydroxyurea treatment (homozygous SCA or combined heterozygous sickle cell/beta thalassemia) were found to be lower than those in patients who responded to treatment, as expected [20]. Here, ZBTB7A is linked to beta thalassemia.